Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adagio Medical Holdings (ADGM) Return on Sales (2023 - 2025)

Adagio Medical Holdings (ADGM) has disclosed Return on Sales for 3 consecutive years, with 17.53% as the latest value for Q4 2025.

  • Quarterly Return on Sales changed N/A to 17.53% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 17.53% through Dec 2025, changed N/A year-over-year, with the annual reading at 98.66% for FY2023, N/A changed from the prior year.
  • Return on Sales for Q4 2025 was 17.53% at Adagio Medical Holdings, down from 19.45% in the prior quarter.
  • The five-year high for Return on Sales was 19.45% in Q3 2025, with the low at 368.0% in Q1 2024.
  • Average Return on Sales over 3 years is 76.16%, with a median of 29.2% recorded in 2024.
  • Peak annual rise in Return on Sales hit 37993bps in 2025, while the deepest fall reached 3661bps in 2025.
  • Over 3 years, Return on Sales stood at 75.76% in 2023, then surged by 53bps to 35.56% in 2024, then soared by 149bps to 17.53% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 17.53%, 19.45%, and 7.41% for Q4 2025, Q3 2025, and Q2 2025 respectively.